Integran Further Advances its Metallurgical Nano-Technology for Biomedical Applications
(firmenpresse) - TORONTO, ONTARIO -- (Marketwire) -- 02/07/13 -- Toronto-based Integran Technologies Inc. (Integran) today announced its first issued patent pertaining to the use of its metallurgical nano-technologies for enhancing the durability, reliability and longevity of biomedical implants. US Patent 8,273,117 discloses a "Low Texture Quasi-Isotropic Stent" having superior mechanical properties for use in the treatment of coronary artery disease.
Integran's CEO Gino Palumbo stated: "We are currently developing several biomedical applications for our nano-engineered materials and we are very pleased that the US Patent & Trademark Office has recognized the applicability of our novel grain boundary engineering (GBE®) nano-technology to conventional metallic implant alloys."
About Integran Technologies, Inc.
Integran is a world leader in advanced metallurgical nano-technologies, providing a broad international base of customers with advanced process & product design solutions through R&D, material sales, contract manufacturing and technology licensing. Integran and its predecessor organizations have been at the forefront of metallurgical nano-technology development for over twenty years. Integran has established an international reputation for excellence in materials technology development and commercialization. Integran owns the intellectual property rights for the cost-effective production of metallurgical nano-structures with over 300 patents and patent filings dealing with the structure, composition, processing and application of its revolutionary materials.
Contacts:
Integran Technologies, Inc.
Rich Emrich
VP Business Development
416 675 6266
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.02.2013 - 13:00 Uhr
Sprache: Deutsch
News-ID 227258
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 228 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Integran Further Advances its Metallurgical Nano-Technology for Biomedical Applications"
steht unter der journalistisch-redaktionellen Verantwortung von
Integran Technologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
